A History of Excellence. GFOA has awarded the City of Wilmington a Certificate of Achievement for Excellence in Financial Reporting for its comprehensive annual financial report, consecutively, since 1984.
Glycine encephalopathy is sometimes referred to as nonketotic hyperglycinemia (NKH), as a reference to the biochemical findings seen in patients with the disorder, and to distinguish it from the disorders that cause ketotic hyperglycinemia (seen in propionic acidemia and several other inherited metabolic disorders).lycine encephalopathy has an estimated incidence of 1 in 60,000, making it the second most common disorder of amino acid metabolism, after phenylketonuria. It is caused by a defect in the glycine cleavage system (GCS), which is made up of four protein subunits.
encephalopathy is a common problem that may be caused by uremia, thiamine deficiency, dialysis, transplant rejection, hypertension, fluid and electrolyte disturbances or drug. toxicity (Mahoney & Arieff, 1982). In this chapter, the symptoms, pathophysiology and. treatment of uremic encephalopathy will be discussed.